BRACHYTHERAPY;
CONTINUOUS VARIABLES;
CURRENT LEVELS;
EFFECT SIZE;
ENDOMETRIAL CANCER;
HIGH DOSE RATE;
MINIMALLY INVASIVE SURGERY;
MULTI VARIATE ANALYSIS;
MULTIVARIATE REGRESSION;
RADIATION ONCOLOGY;
RISK FACTORS;
SEXUAL DYSFUNCTION;
SHORT TIME INTERVALS;
STANDARD DEVIATION;
TIME INTERVAL;
VALIDATION STUDY;
Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial
R.A. Nout, H. Putter, and I.M. Jurgenliemk-Schulz Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial J Clin Oncol 27 2009 3547 3556
Intravaginal brachytherapy alone for intermediate-risk endometrial cancer
K.M. Alektiar, E. Venkatraman, and D.S. Chi Intravaginal brachytherapy alone for intermediate-risk endometrial cancer Int J Radiat Oncol Biol Phys 62 2005 111 117
Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma
D.W. Bruner, R. Lanciano, and M. Keegan Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma Int J Radiat Oncol Biol Phys 27 1993 825 830
Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer
A.Y. Bahng, A. Dagan, and D.W. Bruner Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer Int J Radiat Oncol Biol Phys 82 2012 667 673
The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function
R. Rosen, C. Brown, and J. Heiman The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function J Sex Marital Ther 26 2000 191 208
Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2
J.L. Walker, M.R. Piedmonte, and N.M. Spirtos Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 J Clin Oncol 27 2009 5331 5336
The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores
M. Wiegel, C. Meston, and R. Rosen The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores J Sex Marital Ther 31 2005 1 20
Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression
F.F. Verit, A. Verit, and N. Billurcu Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression Maturitas 64 2009 38 42
Quality of life of patients with endometrial cancer undergoing laparoscopic International Federation of Gynecology and Obstetrics staging compared with laparotomy: A Gynecologic Oncology Group study
A.B. Kornblith, H.Q. Huang, and J.L. Walker Quality of life of patients with endometrial cancer undergoing laparoscopic International Federation of Gynecology and Obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study J Clin Oncol 27 2009 5337 5342
Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer
L.C. Friedman, R. Abdallah, and M. Schluchter Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer Int J Radiat Oncol Biol Phys 80 2010 751 757
Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage i endometrial cancer (LACE): A randomised trial
M. Janda, V. Gebski, and A. Brand Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial Lancet Oncol 11 2010 772 780